Nuedexta for Pseudobulbar Affect Carlat Reports

Nuedexta for Pseudobulbar Affect

The Carlat Psychiatry Report, Volume 10, Number 1, January 2012
https://www.thecarlatreport.com/newsletter-issue/tcprv10n1/

From The Carlat Psychiatry Report, January 2012, Natural Treatments in Psychiatry

Issue Links: Learning Objectives | Editorial Information

Topics: Mood Stabilizers | Natural Medications | Neuroscience in Psychiatry

Steve Balt, MD

Research fellow, Addiction Pharmacology Research Laboratory, California Pacific Medical Center

Dr. Balt discloses that his spouse is employed as a sales representative for Bristol Myers Squibb.

Daniel Carlat, MD

Editor-in-Chief, Publisher, The Carlat Report.

Dr. Carlat has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.

Nuedexta is a combination of dextromethorphan (DM) and quinidine sulfate. You might reasonably ask why these two agents would have ever been considered as a treatment for PBA.

You can't view details of this content, please login or buy subscription here